Completely biological tissue-engineered pulmonic valve grown in vitro from human
从人体体外培养的完全生物组织工程肺动脉瓣
基本信息
- 批准号:8083856
- 负责人:
- 金额:$ 56.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAnimal ModelBenchmarkingBiologicalBioprosthesis deviceBioreactorsCaliberCardiovascular systemCellsChildhoodClinical TrialsCulture MediaDataDepositionDermalDevelopmentDiffusionEngineeringExhibitsFailureFeedbackFibrinFibroblastsFundingGelGenerationsGoalsGrowthHeart ValvesHematopoieticHumanImplantIn VitroInfiltrationLifeMechanicsMesenchymal Stem CellsModelingMonitorNutrientOperative Surgical ProceduresPatientsPerformancePhenotypePhysiologic pulsePlant RootsPolymersPositioning AttributePropertyPulmonary artery structurePulmonary valve structurePumpRadialResearchSeedsSheepSiliconesSmooth Muscle Actin Staining MethodStretchingStroke VolumeSurfaceTechnologyTensile StrengthTestingThinnessTissue EngineeringTissuesTranslatingTransplantationTubeUnited StatesUnited States National Institutes of HealthValidationVariantaortic valveaortic valve replacementdesignhuman tissueimplantationimprovedinterestmortalityoperationpre-clinicalpreimplantationpressurepulmonary valve replacementsuccessvalve replacement
项目摘要
DESCRIPTION (provided by applicant): The goal of this research plan is to translate the progress made with prior NIH funding into a completely biological tissue-engineered pulmonary valve replacement, made of tissue grown in vitro from fibroblast remodeled fibrin. This will be accomplished using (1) advances in heart valve bioreactor design and operation to strengthen the root segment and the root-leaflet attachment line, and (2) a new decellularization and optional recellularization strategy using mesenchymal stem cells to obviate the leaflet contraction that occurred post-implantation due to the transplanted fibroblasts, which are used to grow the tissue valve in vitro. This tissue-engineered heart valve (TEHV), both decellularized (relying on host cell invasion) and recellularized (with mesenchymal stem cells pre-implantation) will be validated in a lamb model to demonstrate growth capacity and sustained function of the engineered valve. Success will ultimately benefit approximately 10,000 pediatric patients in the U.S. annually and ultimately 100,000 patients in the U.S. annually if this TEHV can subsequently be improved to withstand forces associated with the aortic valve position. Enabling technologies relevant to other cardiovascular tissue engineering applications will be generated as a by-product of this research.
PUBLIC HEALTH RELEVANCE: In the United States alone, over 95,000 valve replacement surgeries are now performed annually according to the AHA. While mechanical and bioprosthetic heart valves have made a dramatic impact since their introduction in the 1960's, the 10-year mortality after replacement is still 30-55%. The need is particularly great for pediatric patients, since these valves do not have the capacity to grow. Thus, there is great interest in developing a new generation of tissue-engineered heart valves and this research is aimed at the design and testing of a completely biological living valve replacement.
描述(由申请人提供):本研究计划的目标是将先前NIH资助的进展转化为完全生物组织工程肺动脉瓣置换术,由成纤维细胞重塑纤维蛋白体外生长的组织制成。这将通过以下方式实现:(1)心脏瓣膜生物反应器设计和操作的进步,以加强根段和根-瓣叶附着线,以及(2)使用间充质干细胞的新的脱细胞化和可选的再细胞化策略,以抑制植入后由于移植成纤维细胞而发生的瓣叶收缩,所述成纤维细胞用于体外生长组织瓣膜。这种组织工程心脏瓣膜(TEHV),脱细胞化(依赖于宿主细胞入侵)和再细胞化(植入前使用间充质干细胞)将在羔羊模型中进行验证,以证明工程瓣膜的生长能力和持续功能。如果该TEHV随后能够得到改进以承受与主动脉瓣位置相关的力,则成功将最终使美国每年约10,000名儿科患者受益,并最终使美国每年100,000名患者受益。与其他心血管组织工程应用相关的使能技术将作为本研究的副产品产生。
公共卫生相关性:根据AHA的数据,仅在美国,每年就有超过95,000例瓣膜置换手术。虽然机械和生物人工心脏瓣膜自20世纪60年代引入以来已经产生了巨大的影响,但置换后的10年死亡率仍为30- 55%。儿科患者的需求特别大,因为这些瓣膜没有生长的能力。因此,人们对开发新一代组织工程心脏瓣膜有很大的兴趣,本研究旨在设计和测试完全生物活性的瓣膜置换术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(5)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT T TRANQUILLO其他文献
ROBERT T TRANQUILLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT T TRANQUILLO', 18)}}的其他基金
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing
生物工程经导管静脉瓣膜:设计优化和临床前测试
- 批准号:
10594865 - 财政年份:2023
- 资助金额:
$ 56.87万 - 项目类别:
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients
完全生物组织工程肺动脉瓣,由人体细胞在体外培养,供儿科患者使用
- 批准号:
10188591 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Biopolymer-guided human stem cell assembly for engineered myocardium
生物聚合物引导的人类干细胞组装用于工程化心肌
- 批准号:
8328585 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Perfusable and beating engineered myocardium from human progenitor cells based on
基于人类祖细胞的可灌注和跳动工程心肌
- 批准号:
8138261 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
由人体细胞培育而成的组织工程肺动脉瓣,供儿科患者使用
- 批准号:
8527302 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients
完全生物组织工程肺动脉瓣,由人体细胞在体外培养,供儿科患者使用
- 批准号:
9520733 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
由人体细胞培育而成的组织工程肺动脉瓣,供儿科患者使用
- 批准号:
8242099 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Biopolymer-guided human stem cell assembly for engineered myocardium
生物聚合物引导的人类干细胞组装用于工程化心肌
- 批准号:
8529260 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
由人体细胞培育而成的组织工程肺动脉瓣,供儿科患者使用
- 批准号:
8649073 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
由人体细胞培育而成的组织工程肺动脉瓣,供儿科患者使用
- 批准号:
8828279 - 财政年份:2011
- 资助金额:
$ 56.87万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 56.87万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 56.87万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)